PRODUCT DETAILS

About Chemobort Injection

BORTEZOMIB belongs to a group of anti-cancer medicines used to treat adult patients with multiple myeloma and mantle cell lymphoma who have received at least 1 prior therapy. Multiple myeloma, also known as myeloma, is a type of bone marrow cancer it affects several areas of the body, such as the spine, skull, pelvis, and ribs. Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma (NHL). It develops when B-cells (also called B-lymphocytes) becomes abnormal. B-cells are white blood cells that fight infection.

BORTEZOMIB contains 'Bortezomibx' that works by interfering with how proteasomes work, which may cause cancer cells to die and may stop cancer from growing and eventually kills them.

BORTEZOMIB is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously, or SC). BORTEZOMIB must not be administered into your spinal fluid (intrathecally). You may experience nausea, diarrhea, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), peripheral neuropathy (nerves malfunction), fatigue, neuralgia, anemia, leukopenia, constipation, vomiting, lymphopenia, rash, pyrexia, and anorexia. Most of these side effects of BORTEZOMIB do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Uses of Chemobort Injection

Multiple myeloma and Mantle cell lymphoma.

Medicinal Benefits of Chemobort Injection

BORTEZOMIB contains the active substance bortezomib, also-called ‘proteasome inhibitor’. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells. BORTEZOMIB is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in 18 years or older patients. It can be used alone or together with other medicines.

Directions for Use

BORTEZOMIB is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously, or SC). BORTEZOMIB must not be administered into your spinal fluid (intrathecally). Do not self-administer BORTEZOMIB.

Side Effects of Chemobort Injection

• Nausea
• Diarrhea
• Thrombocytopenia (low blood platelet count)
• Neutropenia (too few neutrophils)
• Peripheral neuropathy (nerves malfunction)
• Fatigue (overtired)
• Neuralgia (pain in the head or face)
• Muscle pain, bone pain
• Anemia (low red blood cell Count)
• Leukopenia (Low White Blood Cell Count)
• High blood pressure
• Constipation
• Dehydration
• Vomiting
• Loss of appetite
• Lymphopenia (Low lymphocytes Count)
• Rash
• Pyrexia (raised body temperature)
• Anorexia (lack or loss of appetite for food)
• Infections, including pneumonia, respiratory infections, bronchitis, fungal infections, coughing with phlegm, flu-like illness

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

To treat your condition effectually, continue taking BORTEZOMIB for as long as your doctor has prescribed. Do not stop BORTEZOMIB midway. Talk to your doctor before taking BORTEZOMIB if you have allergies or if your suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. And also, inform your doctor if you have diabetes because BORTEZOMIB can affect your blood glucose levels. Your doctor may require close monitoring of your blood glucose levels and change your diabetes medicine dose while being treated with BORTEZOMIB. Avoid taking BORTEZOMIB if you are pregnant because this BORTEZOMIB can cause harmful effects on the unborn baby. Both women and men using this BORTEZOMIB should use birth control to avoid pregnancy and at least six months following treatment. Do not breastfeed during treatment with BORTEZOMIB and four months after your final dose of BORTEZOMIB.

Drug-Drug Interaction:

BORTEZOMIB interacts with antifungal medication (ketoconazole), HIV medication (ritonavir), antibiotic medication (rifampicin), epilepsy medications (carbamazepine, phenytoin or phenobarbital), depression medication (St. John’s Wort), and oral antidiabetics.